Literature DB >> 16492828

The ventilatory stimulant doxapram inhibits TASK tandem pore (K2P) potassium channel function but does not affect minimum alveolar anesthetic concentration.

Joseph F Cotten1, Bharat Keshavaprasad, Michael J Laster, Edmond I Eger, C Spencer Yost.   

Abstract

TWIK-related acid-sensitive K(+)-1 (TASK-1 [KCNK3]) and TASK-3 (KCNK9) are tandem pore (K(2P)) potassium (K) channel subunits expressed in carotid bodies and the brainstem. Acidic pH values and hypoxia inhibit TASK-1 and TASK-3 channel function, and halothane enhances this function. These channels have putative roles in ventilatory regulation and volatile anesthetic mechanisms. Doxapram stimulates ventilation through an effect on carotid bodies, and we hypothesized that stimulation might result from inhibition of TASK-1 or TASK-3 K channel function. To address this, we expressed TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric, and TASK-1/TASK-3 chimeric K channels in Xenopus oocytes and studied the effects of doxapram on their function. Doxapram inhibited TASK-1 (half-maximal effective concentration [EC50], 410 nM), TASK-3 (EC50, 37 microM), and TASK-1/TASK-3 heterodimeric channel function (EC50, 9 microM). Chimera studies suggested that the carboxy terminus of TASK-1 is important for doxapram inhibition. Other K2P channels required significantly larger concentrations for inhibition. To test the role of TASK-1 and TASK-3 in halothane-induced immobility, the minimum alveolar anesthetic concentration for halothane was determined and found unchanged in rats receiving doxapram by IV infusion. Our data indicate that TASK-1 and TASK-3 do not play a role in mediating the immobility produced by halothane, although they are plausible molecular targets for the ventilatory effects of doxapram.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492828     DOI: 10.1213/01.ane.0000194289.34345.63

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  30 in total

Review 1.  Molecular approaches to improving general anesthetics.

Authors:  Stuart A Forman
Journal:  Anesthesiol Clin       Date:  2010-12

2.  Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.

Authors:  Rikki H Chokshi; Aaron T Larsen; Brijesh Bhayana; Joseph F Cotten
Journal:  Mol Pharmacol       Date:  2015-08-12       Impact factor: 4.436

Review 3.  A new look at the respiratory stimulant doxapram.

Authors:  C Spencer Yost
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

4.  Diaphragm remodeling and compensatory respiratory mechanics in a canine model of Duchenne muscular dystrophy.

Authors:  A F Mead; M Petrov; A S Malik; M A Mitchell; M K Childers; J R Bogan; G Seidner; J N Kornegay; H H Stedman
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

5.  Glial cells are involved in the exciting effects of doxapram on brainstem slices in vitro.

Authors:  Guo-cai Li; Hong-tian Zhang; Yong-gang Jiao; Zhong-hai Wu; Fang Fang; Jing Cheng
Journal:  Cell Mol Neurobiol       Date:  2010-02-07       Impact factor: 5.046

6.  Repeated intravenous doxapram induces phrenic motor facilitation.

Authors:  M S Sandhu; K Z Lee; E J Gonzalez-Rothi; D D Fuller
Journal:  Exp Neurol       Date:  2013-09-04       Impact factor: 5.330

7.  Chronic hypoxia increases the gain of the hypoxic ventilatory response by a mechanism in the central nervous system.

Authors:  Katherine A Wilkinson; Kimberly Huey; Bruce Dinger; Liang He; Salvatore Fidone; Frank L Powell
Journal:  J Appl Physiol (1985)       Date:  2010-05-20

8.  Regional expression of the anesthetic-activated potassium channel TRESK in the rat nervous system.

Authors:  SieHyeon Yoo; Jia Liu; Marta Sabbadini; Paul Au; Guo-xi Xie; C Spencer Yost
Journal:  Neurosci Lett       Date:  2009-08-27       Impact factor: 3.046

9.  New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Authors:  Jourdan A Andersson; Eric C Fitts; Michelle L Kirtley; Duraisamy Ponnusamy; Alex G Peniche; Sara M Dann; Vladimir L Motin; Sadhana Chauhan; Jason A Rosenzweig; Jian Sha; Ashok K Chopra
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

10.  Knockout of the gene encoding the K(2P) channel KCNK7 does not alter volatile anesthetic sensitivity.

Authors:  C Spencer Yost; Irene Oh; Edmond I Eger; James M Sonner
Journal:  Behav Brain Res       Date:  2008-05-20       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.